HAVEN-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Deep Venous Thrombosis
- Pulmonary Embolism
- Quality Improvement
- Venous Thromboembolic Disease
- Venous Thromboembolism
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 14 years and 125 years
- Gender
- Both males and females
Description
Hospitals nationwide which have willingness to participate this study in CURES group will be selected. Each selected hospital will be regarded as a cluster and randomized into interventional or control group. During the study period, eligible patients enrolled in hospitals assigned to interventional...
Hospitals nationwide which have willingness to participate this study in CURES group will be selected. Each selected hospital will be regarded as a cluster and randomized into interventional or control group. During the study period, eligible patients enrolled in hospitals assigned to interventional group will receive a variety of the multifaceted quality improvement(QI) interventions, including mandatory risk assessment, a computer alert(computer-based clinical decision support system and computerized reminders), strengthened education, and audit. Patients in hospitals assigned to control group will receive common recommended care only, or an existing policy.
Tracking Information
- NCT #
- NCT04211181
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Zhenguo Zhai, Doctor China-Japan Friendship Hospital
Get Well Soon